Knee Bursitis Market Size Forecasted To Achieve $3.79 Billion By 2029 With Steady Growth

The Knee Bursitis Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Knee Bursitis Market Size and Projected Growth Rate?
The knee bursitis market has shown strong growth in recent years. It is projected to grow from $2.66 billion in 2024 to $2.86 billion in 2025, with a compound annual growth rate (CAGR) of 7.6%. This growth is driven by an aging population, increased participation in sports and physical activities, better diagnostic techniques, improved access to healthcare services, and educational programs for healthcare professionals and patients.

The knee bursitis market is expected to experience solid growth, reaching $3.79 billion by 2029 at a CAGR of 7.3%. This is driven by awareness campaigns about prevention and management, increasing disposable income, rising healthcare expenditure, and improved diagnosis of knee bursitis. Major trends include advancements in diagnostic techniques, novel therapy development, progress in research, and the growth of telemedicine and remote monitoring.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16460

What Are the Major Segments in the Knee Bursitis Market?
The knee bursitis market covered in this report is segmented -

1) By Diagnosis: Imaging Test, Other Diagnosis Tests
2) By Treatment: Medication, Therapy, Surgery, Other Treatments
3) By End User: Hospitals And Clinics, Diagnostic Centers, Research Centers, Academic Institutes, Other End Users

Subsegments:
1) By Imaging Test: X-Ray, MRI (Magnetic Resonance Imaging), Ultrasound
2) By Other Diagnosis Tests: Physical Examination, Aspiration Of Joint Fluid, Blood Tests

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16460&type=smp

What Are The Driving Knee Bursitis Market Evolution?
The increasing prevalence of bone-related diseases is expected to propel the growth of the knee bursitis market going forward. Bone-related diseases encompass conditions such as osteoporosis, arthritis, and bone cancer, affecting the structure, strength, and function of the skeletal system. The increasing prevalence of bone-related diseases is attributed to factors such as aging populations, sedentary lifestyles, poor nutrition, and environmental changes. Bone-related diseases such as osteoarthritis and rheumatoid arthritis can lead to knee bursitis by causing inflammation and excessive pressure on the knee bursa. This inflammation results in pain, swelling, and reduced joint function. For instance, in September 2022, a report by Healthy Bones Australia, an Australia-based non-profit organization, projected that in 2022, Australia is estimated to have 6.2 million individuals aged 50 and above suffering from osteoporosis or osteopenia. This calculation is based on the fact that 22% have osteoporosis and 78% have osteopenia among the 4.74 million Australians with poor bone health. Therefore, the increasing prevalence of bone-related retailers is driving the growth of the knee bursitis market.

Which Firms Dominate The Knee Bursitis Market Segments?
Major companies operating in the knee bursitis market are Pfizer Inc., Merck & Co. Inc, Bayer AG, Novartis AG, Roche Holding AG, Medtronic plc, Eli Lilly and Company, Amgen Inc, Gilead Sciences Inc., Stryker Corporation, Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Incorporated, Zimmer Biomet Holdings Inc., DePuy Synthes Inc., Arthrex Inc., Globus Medical Inc., Bioventus LLC, Exactech Inc., Genentech Inc., Conformis Inc., Oncolys BioPharma Inc, Bellicum Pharmaceuticals Inc, Merrimack Pharmaceuticals Inc, 4Med Medical Solutions Inc

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/knee-bursitis-global-market-report

Which Is The Largest Region In The Knee Bursitis Market?
North America was the largest region in the knee bursitis market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the knee bursitis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Knee Bursitis Market?
2. What is the CAGR expected in the Knee Bursitis Market?
3. What Are the Key Innovations Transforming the Knee Bursitis Industry?
4. Which Region Is Leading the Knee Bursitis Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.